An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

This study is looking at a new oral drug to treat acne. All patients in the study will get active drug, there is no placebo arm.

Phase 2

Stiefel, a GSK Company

R 115866